Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma

References

• Einhorn LH. Treatment of testicular cancer: A new and improved model. J Clin Oncol 1990;8:1777–81.
   PubMed Web of Science ®Google Scholar
• Friedman N. Supervoltage (1 million volts) roentgen therapy at Walter Reed General Hospital. Surg Clin N Am 1944; 24:1424–32.
   Google Scholar
• Oliver RTD, Hope-Stone HF, Blandy JP. Possible new approaches to the management of seminoma of the testis. Br J Urol 1984;56:729–33.
   PubMedGoogle Scholar
• Horwich A, Dearnaley DP, A’Hern R, Mason M, Thomas G, Jay G, et al. The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer 1992;28A:1307–10.
   PubMed Web of Science ®Google Scholar
• Oliver RT, Lore S, Ong J. Alternatives to radiotherapy in the management of seminoma. Br J Urol 1990;65:61–7.
   PubMedGoogle Scholar
• Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann JT, Horwich A, Clemm C, et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomised trials. Br J Cancer 2004;91:683–7.
   PubMed Web of Science ®Google Scholar
• Gore M, Mainwaring P, A’Hern R, MacFarlane V, Slevin M, Harper P, et al. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol 1998;16:2426–34.
   PubMed Web of Science ®Google Scholar
• Oliver R, Powles T, Ell P, Somasundram U, Shamash J. 22 year phase study of single agent carboplatin in metastatic seminoma: Potential for acceleration by a new surrogate end point, 72 hr PET scan response?J Clin Oncol (Meeting Abstracts) 2006;24:14565.
   Google Scholar
• Glendenning JL, Barbachano Y, Norman AR, Dearnaley DP, Horwich A, Huddart RA. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer. Cancer 2010;116:2322–31.
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996;14:2923–32.
   PubMed Web of Science ®Google Scholar
• Fossa SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 2007;99:533–44.
   PubMedGoogle Scholar
• Fossa SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003;21:1107–18.
   PubMed Web of Science ®Google Scholar
• Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008;19:443–7.
   PubMed Web of Science ®Google Scholar
• Sakaeda T, Kadoyama K, Okuno Y. Adverse event profiles of platinum agents: Data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations. Int J Med Sci 2011;8:487–91.
   PubMed Web of Science ®Google Scholar
• International Germ Cell Consensus Classification:A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594–603.
   PubMed Web of Science ®Google Scholar
• Matakidou A, Mutsvangwa K, Ansell W, Lim L, Powles TB, Oliver RT, et al. Single-agent carboplatin AUC 10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group. Ann Oncol 2010;21:1730–1.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A editors. AJCC cancer staging manual, 7th ed. New York, NY: Springer; 2010.
   Google Scholar
• Garcia-del-Muro X, Maroto P, Guma J, Sastre J, Lopez Brea M, Arranz JA, et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008;26:5416–21.
   PubMed Web of Science ®Google Scholar
• Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, et al. Management of seminomatous testicular cancer: A binational prospective population-based study from the Swedish Norwegian Testicular Cancer Study Group. J Clin Oncol 2011;29:719–25.
   PubMed Web of Science ®Google Scholar
• Kollmannsberger C, Tyldesley S, Moore C, Chi KN, Murray N, Daneshmand S, et al. Evolution in management of testicular seminoma: Population-based outcomes with selective utilization of active therapies. Ann Oncol 2011; 22:808–14.
   PubMed Web of Science ®Google Scholar
• Krege S, Boergermann C, Baschek R, Hinke A, Pottek T, Kliesch S, et al. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 2006;17:276–80.
   PubMed Web of Science ®Google Scholar
• Gilbert DC, Vanas NJ, Beesley S, Bloomfield D, Money-Kyrle J, Norman A, et al. Treating IIA/B seminoma with combination carboplatin and radiotherapy. J Clin Oncol 2009;27:2101–2; author reply 2–3.
   PubMed Web of Science ®Google Scholar
• Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 2005;97:1354–65.
   PubMed Web of Science ®Google Scholar
• Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, et al. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Br J Cancer 2000; 83:1623–9.
   PubMed Web of Science ®Google Scholar
• Fossa SD, Langmark F, Aass N, Andersen A, Lothe R, Borresen AL. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990;61:639–43.
   PubMed Web of Science ®Google Scholar
• Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 2011;29:2821–6.
   PubMed Web of Science ®Google Scholar